COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,846 Articles (22,553 medRxiv, 8,293 bioRxiv)

Most recent first Previous |  Page 748: Articles 7471-7480  | Next

Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID-19 initiation in human lung
Wu, T. T.-H., Travaglini, K. J., Rustagi, A., Xu, D., Zhang, Y., Jang, S. K., Gillich, A., Dehghannasiri, R., Martinez-Colon, G., Beck, A., Wilk, A. J., Morri, M., Trope, W. L., Shrager, J. B., Quake, S. R., Kuo, C. S., Salzman, J., Kim, P. S., Blish, C. A., Krasnow, M. A.
10.1101/2022.05.10.491266 — Posted: 2022-05-10
COVID-19 mRNA third dose induces a unique hybrid immunity-like antibody response
Andreano, E., Paciello, I., Pierleoni, G., Piccini, G., Abbiento, V., Antonelli, G., Pileri, P., Manganaro, N., Pantano, E., Maccari, G., Marchese, S., Donnici, L., Benincasa, L., Giglioli, G., Leonardi, M., De Santi, C., Fabbiani, M., Rancan, I., Tumbarello, M., Montagnani, F., Sala, C., Medini, D., De Francesco, R., Montomoli, E., Rappuoli, R.
10.1101/2022.05.09.491201 — Posted: 2022-05-10
Unrealistic optimism in the eye of the storm: Positive bias towards the consequences of COVID-19 during the second and third waves of the pandemic.
Maksim, A., Spiewak, S., Lipp, N., Duzmanska-Misiarczyk, N., Rebilas, K., Gustaw, G., Strojny, P.
10.1101/2022.05.10.22274918 — Posted: 2022-05-10
BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants
Roessler, A., Netzl, A., Knabl, L., Schaefer, H., Wilks, S. H., Bante, D., Falkensammer, B., Borena, W., von Laer, D., Smith, D., Kimpel, J.
10.1101/2022.05.10.22274906 — Posted: 2022-05-10
Influencing factors of Anti-SARS-CoV-2-Spike IgG antibody titres in healthcare workers - A cross-section study
Reusch, J., Wagenhaeuser, I., Gabel, A., Eggestein, A., Hoehn, A., Lam, T.-T., Frey, A., Schubert-Unkmeir, A., Doelken, L., Frantz, S., Kurzai, O., Vogel, U., Krone, M., Petri, N.
10.1101/2022.05.10.22274912 — Posted: 2022-05-10
Performance of Existing and Novel Symptom- and Antigen Testing-Based COVID-19 Case Definitions in a Community Setting
Lee, S., Almendares, O., Prince-Guerra, J. L., Heilig, C. M., Tate, J. E., Kirking, H. L.
10.1101/2022.05.10.22274914 — Posted: 2022-05-10
Too much to mask: determinants of sustained adherence to COVID-19 preventive measures among older Syrian refugees in Lebanon
Salti, N., McCall, S., Abi Zeid, B., El Salibi, N., Alawieh, M., Ramadan, Z., Ghattas, H., Abdulrahim, S.
10.1101/2022.05.10.22274919 — Posted: 2022-05-10
Comparison of pandemic excess mortality in 2020-2021 across different empirical calculations
Levitt, M., Zonta, F., Ioannidis, J. P. A.
10.1101/2022.05.09.22274863 — Posted: 2022-05-10
Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries
Liu, Y., Pearson, C. A., Madriz Montero, A., Torres-Rueda, S., Asfaw, E., Uzochukwu, B., Drake, T., Bergren, E., Eggo, R. M., Ruiz, F., Ndembi, N., Nonvignon, J., Jit, M., Vassall, A.
10.1101/2022.05.09.22274846 — Posted: 2022-05-10
Knowledge mobilization activities to support decision-making by youth, parents, and adults using a systematic and living map of evidence and recommendations on COVID-19: protocol for a randomized controlled trial
Charide, R., Stallwood, L., Munan, M., Sayfi, S., Hartling, L., Butcher, N. J., Offringa, M., Elliott, S., Richards, D. P., Mathew, J. L., Akl, E. A., Kredo, T., Motillal, A., Baba, A., Prebeg, M., Relihan, J., Scott, S. D., Suvada, J., Falavigna, M., Klugar, M., Lotfi, T., Stevens, A., Pottie, K., Schünemann, H. J.
10.1101/2022.05.09.22274842 — Posted: 2022-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).